Cellebrite DI Ltd. Return on Equity (ROE) for the Trailing 12 Months (TTM) ending March 31, 2025: -81.13%

Cellebrite DI Ltd. Return on Equity (ROE) is -81.13% for the Trailing 12 Months (TTM) ending March 31, 2025, a -88.58% change year over year. Return on equity measures profit against shareholder equity; higher ROE indicates superior profitability and value creation.
  • Cellebrite DI Ltd. Return on Equity (ROE) for the Trailing 12 Months (TTM) ending March 31, 2024 was -710.22%, a -1,510.73% change year over year.
  • Cellebrite DI Ltd. Return on Equity (ROE) for the Trailing 12 Months (TTM) ending March 31, 2023 was 50.34%, a -114.09% change year over year.
  • Cellebrite DI Ltd. Return on Equity (ROE) for the Trailing 12 Months (TTM) ending March 31, 2022 was -357.27%.
Key Data
Date Return on Equity (ROE) Return on Assets (ROA) Revenue Per Share Free Cash Flow Per Share